It paid $1bn for asset less than three years ago
Three of agency’s reviewers recommended rejecting the drug, used to treat low libido
Deal comes days after final US approval for controversial drug
Flibanserin has been hailed as a cure for loss of female libido, but doubts remain
FDA panel backs ‘Viagra for women’ after two rejections and a controversial lobbying campaign
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices